Thomas Niel

Thomas Niel

InvestorPlace Contributor

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

At Below $3 Clover Health Stock May Be Worth It as a Moonshot

By Thomas Niel, InvestorPlace Contributor

With CLOV stock, it may be worth rolling the dice at today's prices. 

Wait for Matterport Stock to Bottom Out Before Buying

By Thomas Niel, InvestorPlace Contributor

Matterport's spatial data business has high potential, but MTTR stock will continue to drop as meta-minded fair weather fans jump ship.

Even With Multi-Month Drop, It’s Too Early to Bottom-Fish QuantumScape Stock

By Thomas Niel, InvestorPlace Contributor

It's worth keeping an eye on it. It'll likely continue to make wild moves, in either direction. Yet until QS stock reaches the point where it's been truly oversold, it's best to hold off buying.

7 Penny Stock Bubbles That Are Bound to Burst

By Thomas Niel, InvestorPlace Contributor

Watch out with these seven penny stocks, a mix of plays that are still flying high, and a few that have already seen their bubble deflate.

Novavax Stock is in a Tough Spot, but its Fortunes Could Improve

By Thomas Niel, InvestorPlace Contributor

Once the vaccine maker starts booking big sales internationally, NVAX stock could make a trip back to much higher prices.

Buy Sofi Technologies Stock If There’s Another Rate Hike Selloff

By Thomas Niel, InvestorPlace Contributor

If news of an even greater rise to interest rates rattles the markets, you may want to seize the opportunity to scoop up some SOFI stock.

Digital World Stock Could Keep on Winning in the Short Term

By Thomas Niel, InvestorPlace Contributor

It may continue to perform well in the near-term, but there's still little reason to make DWAC stock a buy-and-hold position.

There Are Many Crypto Bargains Out There. Dogecoin Isn’t One of Them.

By Thomas Niel, InvestorPlace Contributor

Still the "show me" coin, there's no need to buy Dogecoin until DOGE demonstrates that it's going to materially enhance its utility.

7 Best Mutual Funds to Buy for the Coming Rate Hikes

By Thomas Niel, InvestorPlace Contributor

As the Fed "returns to normal" with interest rates, investors need to adapt. If you are active in mutual funds, these seven are perfect names to move into, before rates go up. Avantis U.S. Small Cap Value Fund  (MUTF:AVUVX) Brandywine Global High Yield Fund (MUTF:BGHAX) Fidelity Series Intrinsic Opportunities Fund (MUTF:FDMLX) Delaware Ivy S&P 500 Dividend Aristocrats Index Fund (MUTF:IDAAX) Invesco Rochester Municipal Opportunities Fund (MUTF:ORNAX) Vanguard Equity Income Fund (MUTF:VEIPX) Vanguard Financials Index Fund (MUTF:VFAIX)

Cardano Is Poised for a Comeback That Could Eventually Rival Ethereum

By Thomas Niel, InvestorPlace Contributor

Consider it still worthwhile to buy Cardano as a long-term wager on both blockchain finance gaining critical mass, and this crypto's blockchain becoming one of the more widely used ones out there.

Load More